Skip to main content

Home/ Stock Trading School/ Group items tagged Down

Rss Feed Group items tagged

Brian Plain

Dendreon (DNDN) Huge Drop Down 16.4% In After-Hours Trading - - 0 views

  •  
    DNDN Closed at $32.35 and continued to decline in the After Hours Trading Session down to $25. It's currently paired its losses by $2 off the after hours lows. DNDN Dendreon: CMS received informal inquiries for NCD for autologous. The entire after hours decline was done on extremely light volume as bids lighted up and traders sold down the bid. As soon as the lows were established volume came in and there were several large orders of 71,450.
Brian Plain

Pre-Market Stock Futures Gapping Down Sharply Nasdaq, Dow, S&P 500 8/11/2010 - 0 views

  •  
    Equity futures are trading sharply lower this morning, with S&P futures -14 vs. fair value and DJ futures -116. While the initial U.S. market reaction to yesterday's FOMC policy directive was positive, helping the major averages recoup a portion of their losses, overseas markets have responded negatively and are mostly lower.Economy Videos, Day Trading Videos, Commodity Trading Videos, Trading Tutorial Videos
Brian Plain

StockMarketFunding Featured Review by JimM888 - Viewpoints.com - 0 views

  •  
    I almost don't want to let the secret out! When everyone is looking for the "Holy Grail" and you find it. Those are mighty big words, but when you have been down all the avenues, attending weekend seminars, buying videos, DVDs, books, and stock market message boards and getting the same results. Then you attend Stock Market Funding and see it work,.. you are left speechless. Why? I will tell you that I have never had a trainer or a teacher as passionate about the market and interested in sharing the knowledge and expertise. The Market Maker platform works flawlessly and if it has any flaws it would only be a result of a trader not following the information that the pro trading platform gives you. I have been to those "weekend seminars" (when the market is closed) and hear all these grand stories of making a living trading the markets and you can too.! Well that is giving someone the keys to a 747 and no manual to fly it. You will ultimately crash before you take off. The CEO Mario is just amazing with his years of experience and insight. His dedication to his students and senior traders is almost beyond words. I have been truly been give a gift in life coming into the 5 day program and seeing this and working with fellow traders all with the same goal in life, to learn and excel with excellence.
Stock Market

FREE STOCK MARKET TIPS WITH NIFTY TREND 27-DEC-11 - 1 views

  •  
    The markets opened in the negative territory today. At present, both the indices are trading very flat with the Sensex down 11 points at 15959 and Nifty down by 3 points at 4775. Banking stocks were under selling pressure, falling nearly 0.5 per cent. Auto and FMCG stocks also traded lower.
Brian Plain

Dendreon DNDN Trading Video Huge Drop in After Hours - 0 views

  •  
    http://www.StockMarketFunding.com Pt 2 Dendreon Huge Drop Down 16.4% In After-Hours Commentary (VIDEO) DNDN Trading Video Dendreon Cancer Drug Dendreon DNDN Update Dendreon's Cancer Vaccine Provenge -- Dendreon Corporation (Nasdaq:DNDN - News) announced that the Centers for Medicare and Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) of PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). PROVENGE is the first in a new therapeutic class known as autologous cellular immunotherapies. In CMS's announcement of the NCA, CMS is requesting public comments on the effects of PROVENGE on health outcomes in patients with prostate cancer. It is not a change in Medicare coverage policy. NCAs do not impact existing coverage decisions, nor do they restrict local Medicare contractors from covering PROVENGE. Therefore, Medicare beneficiaries are still able to access PROVENGE and private payers can also still cover PROVENGE. Dendreon welcomes the opportunity to continue our discussions with CMS about how PROVENGE will be provided to Medicare beneficiaries, particularly given the survival benefit and safety profile of PROVENGE. We plan on continuing to work closely with CMS during this process to ensure patients with advanced prostate cancer have broad access to PROVENGE. Clinical Trial Results Supporting U.S. Food and Drug Administration (FDA) Approval
pete kelvinson

stock market investors - 0 views

  •  
    Stock sliding in a country like US was never thought but happened and the entire economy of US has sunk down. As the shares of stocks have significantly lower down day after day, the whole economy diminished radically.
Brian Plain

Stock Trading Education Weekly Short In Play Amazon.com AMZN - Stock Trading Videos - 0 views

  •  
    Stock trading education weekly short in play Amazon.com AMZN. In this weekly stock market training education on Amazon.com (AMZN) technical analysis trends for 2013 we'll cover the sell down on the Amazon downgrade and how to trade Amazon going into next week's weekly options expiration cycle.
  •  
    Hi guys, I am new to trading but I want to learn as much as possible about it. Who can share good sources? I want to figure out all the details. Actually, I am a business owner but I want to earn more money and trading seems to be a good option. By the way, I couldn't even imagine that email marketing is so effective. Thanks to it, I managed to attract many new customers. In addition, I can recommend this tool https://emailindetail.com/view-emails
jetrade0

Currency Derivatives Market Watch - 0 views

  •  
    Currency Derivatives are very efficient risk management tool for market. We continuously watch all ups and down in stock market. Customer's business will be secure with us with all latest updates. Track & Trade in currency markets on the BSE Currency Derivatives segment.
1 - 8 of 8
Showing 20 items per page